Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
The registry lists 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma studies with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor. 1 are open to participants now and 2 have results posted.
Early Phase 1 2Phase 1 5Phase 2 3No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesRecruitingNCT06398457Early Phase 1
- Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic CancersTerminatedNCT01135329Phase 2Results posted
- Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood CancersTerminatedNCT00539656Phase 1/2Results posted
- A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission MaintenanceActive, not recruitingNCT03114865Phase 1/2
- Red Cell Transfusion Goals in Patients With Acute LeukemiasCompletedNCT02086773Phase 1
- A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALLCompletedNCT02046694Early Phase 1
- Endothelial Function, Arterial Stiffness and ComponentsCompletedNCT01439217
- Studying Fentanyl in Patients With CancerTerminatedNCT00899951
- Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute LeukemiasTerminatedNCT00852709Phase 1
- Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell TransplantTerminatedNCT00469820Phase 1